title: The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.
abstract: To elucidate further the possible role of the tryptophan, rate-limiting enzyme indoleamine 2, 3-dioxygenase (IDO) in leprosy, the distribution of IDO-positive cells and IDO activity in the skin biopsies and sera of these patients representing the entire spectrum of the disease were studied. An increased number of macrophages/dendritic cells (DC-lineage IDO(+) cells were found in lepromatous (LL) compared to tuberculoid (BT) and reversal reaction (RR) patients. IDO-positive cells showing CD68 and CD86 surface markers predominated in LL lesions, while higher levels of IDO activity were observed in the sera of LL versus BT patients. Tests revealed an increased IDO message in Mycobacterium leprae-stimulated peripheral blood mononuclear cells (PBMC) by real-time polymerase chain reaction (PCR) and increased IDO expression in M. leprae-stimulated CD14(+) cells of both healthy controls (HC) and LL patients, as evaluated via flow cytometry. Increased M. leprae-induced IDO-protein synthesis was also confirmed by Western blot. Based on our in vitro studies, it was confirmed that M. leprae up-regulated IDO expression and activity in HC and LL monocytes. Interferon (IFN)-γ synergized with M. leprae in promoting IDO expression and activity in monocytes. IDO expression induced by both IFN-γ and M. leprae was abrogated by 1-methyltryptophan (1-MT). Our data suggest that M. leprae chronic infection activates the suppressive molecule IDO which, in turn, contributes to the specific immunosuppression observed in LL leprosy.
authors: Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz - Rio de Janeiro, Brazil.
authors: J
authors: J
authors: de Souza Sales
authors: F A
authors: FA
authors: Lara
authors: T P
authors: TP
authors: Amadeu
authors: T
authors: T
authors: de Oliveira Fulco
authors: J A
authors: JA
authors: da Costa Nery
authors: E P
authors: EP
authors: Sampaio
authors: R O
authors: RO
authors: Pinheiro
authors: E N
authors: EN
authors: Sarno
references: Immunol Rev. 2008 Apr;222:206-21
references: 18364004
references: Cell Death Differ. 2002 Oct;9(10):1069-77
references: 12232795
references: Lepr Rev. 2008 Dec;79(4):372-86
references: 19274984
references: J Immunol. 1993 Jun 15;150(12):5501-10
references: 8515073
references: J Exp Med. 1985 Sep 1;162(3):917-29
references: 3928804
references: Nat Rev Immunol. 2008 Dec;8(12):958-69
references: 19029990
references: Mater Med Pol. 1989 Jul-Sep;21(3):244-50
references: 2491278
references: Infect Immun. 1993 Jan;61(1):197-203
references: 8418042
references: Curr Pharm Des. 2003;9(3):257-64
references: 12570830
references: J Biol Chem. 2007 Aug 17;282(33):23778-87
references: 17535808
references: J Gen Virol. 2009 Apr;90(Pt 4):810-817
references: 19264674
references: Am J Pathol. 2007 Dec;171(6):1936-43
references: 18055547
references: Clin Cancer Res. 2009 Jan 1;15(1):390-9
references: 19118070
references: J Clin Invest. 2007 May;117(5):1147-54
references: 17476344
references: Mucosal Immunol. 2008 Nov;1(6):432-41
references: 19079210
references: Br J Dermatol. 2003 Apr;148(4):795-8
references: 12752141
references: Clin Chem. 1997 Dec;43(12):2424-6
references: 9439467
references: Science. 1995 Oct 13;270(5234):283-6
references: 7569975
references: Immunol Lett. 2000 Dec 1;75(1):69-76
references: 11163869
references: Immunology. 2003 May;109(1):156-64
references: 12709029
references: J Neurosci. 2009 Apr 1;29(13):4200-9
references: 19339614
references: Int J Lepr Other Mycobact Dis. 1980 Jun;48(2):172-7
references: 7190553
references: Am J Pathol. 2010 May;176(5):2082-7
references: 20228228
references: Nat Med. 2005 Jun;11(6):653-60
references: 15880118
references: J Mol Med (Berl). 2008 Feb;86(2):145-60
references: 17876564
references: Infect Immun. 2001 Oct;69(10):6527-31
references: 11553600
references: Immunol Lett. 2008 Nov 16;121(1):1-6
references: 18824197
references: J Exp Med. 1992 Jun 1;175(6):1729-37
references: 1588290
references: Cancer Immunol Immunother. 2009 Jan;58(1):153-7
references: 18418598
references: J Leukoc Biol. 2010 Mar;87(3):371-84
references: 19952355
references: J Immunol. 2008 Aug 1;181(3):2220-6
references: 18641362
references: Nature. 2001 Feb 22;409(6823):1007-11
references: 11234002
references: Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73
references: 5950347
references: Adv Exp Med Biol. 1996;398:285-9
references: 8906279
references: Microbes Infect. 2009 Jan;11(1):133-41
references: 19007906
references: Immunogenetics. 2001 Feb;53(1):45-7
references: 11261930
references: Fundam Clin Pharmacol. 2009 Oct;23(5):573-81
references: 19656212
references: N Engl J Med. 2009 Dec 31;361(27):2609-18
references: 20018961
references: Infect Immun. 1985 Dec;50(3):887-92
references: 2933339
references: J Immunol. 2008 Apr 15;180(8):5157-62
references: 18390695
references: FASEB J. 2007 Nov;21(13):3450-7
references: 17551098
references: FASEB J. 2010 Aug;24(8):2689-701
references: 20233946
references: Br J Dermatol. 2007 Aug;157(2):273-83
references: 17553031
references: Am J Pathol. 1987 Aug;128(2):345-53
references: 3113256
references: J Clin Invest. 2006 Dec;116(12):3160-70
references: 17111046
references: Immunol Lett. 2007 May 15;110(1):82-5
references: 17462745
references: Adv Exp Med Biol. 2003;527:183-90
references: 15206731
references: J Infect Dis. 2010 Mar 15;201(6):956-66
references: 20151841
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Science. 1991 Oct 11;254(5029):277-9
references: 1925582
references: Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8
references: 18952840
references: J Clin Invest. 2004 Feb;113(3):401-13
references: 14755337
references: Science. 1998 Aug 21;281(5380):1191-3
references: 9712583
references: Scand J Immunol. 1999 Nov;50(5):541-9
references: 10564558
references: Nat Immunol. 2008 Apr;9(4):353-9
references: 18349815
references: J Infect Dis. 2000 Jan;181(1):302-8
references: 10608779
references: J Immunol. 2008 Nov 1;181(9):5829-35
references: 18941170
references: J Immunol. 1986 Nov 1;137(9):2831-4
references: 2944966